Citation Tools
PDFRegular and Young Investigator Award Abstracts
Combination Immunotherapies
825 α-CD38 therapy reverses α-PD1 resistance when used in a proper biologic schedule; explaining and overcoming previous failures of the combination in clinical trials
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- 825 α-CD38 therapy reverses α-PD1 resistance when used in a proper biologic schedule; explaining and overcoming previous failures of the combination in clinical trials